SCHEMBL6564697

SCHEMBL6564697

COC(=O)c1cc(NC(=O)Nc2ccccc2)ccc1OCc1ccccc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HIF1A Q16665 5/20 0.54
MAPT P10636 5/20 0.51
ALDH1A1 P00352 3/20 0.51
GAA P10253 2/20 0.51
RAB9A P51151 2/20 0.51
SGMS2 Q8NHU3 1/20 0.49
ALOX5 P09917 1/20 0.48
EPHX2 P34913 1/20 0.48
ESRRA P11474 1/20 0.48
POLB P06746 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 1/20 0.45
PPIA P62937 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567857 0.90 MEN1 (0.53) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6565833 0.90 MEN1 (0.53) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6566712 0.88 MEN1 (0.65) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6565955 0.88 KMT2A (0.55) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6566692 0.86 MEN1 (0.61) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6567662 0.85 MEN1 (0.52) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6564360 0.84 MEN1 (0.54) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6566726 0.84 MEN1 (0.56) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6566664 0.83 MEN1 (0.57) MEN1KMT2ALMNASMN1; SMN2HIF1A
SCHEMBL6566663 0.83 MEN1 (0.52) MEN1KMT2ALMNASMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MEN1 4143/4885KMT2A 3137/4885LMNA 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.